Long-Term Safety Follow-Up of Subjects Previously Treated with Non-Replicating Retroviral Vector-Based Gene Therapies
Crossref DOI link: https://doi.org/10.1007/s40291-016-0229-9
Published Online: 2016-07-19
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mohanlal, Ramon
Qiu, Yuhong
Zheng, Ming
Mirkou, Asmae
Sridharan, Kanaka
Keir, Christopher
Funding for this research was provided by:
Novartis Oncology
License valid from 2016-07-19